[
  {
    "ts": null,
    "headline": "Solventum (SOLV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates",
    "summary": "Although the revenue and EPS for Solventum (SOLV) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
    "url": "https://finnhub.io/api/news?id=55e9a2fae6e866e0ffaef003b0d7d6471ffc01425142d47442027455fc12d3c8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754604003,
      "headline": "Solventum (SOLV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates",
      "id": 136268113,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SOLV",
      "source": "Yahoo",
      "summary": "Although the revenue and EPS for Solventum (SOLV) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
      "url": "https://finnhub.io/api/news?id=55e9a2fae6e866e0ffaef003b0d7d6471ffc01425142d47442027455fc12d3c8"
    }
  },
  {
    "ts": null,
    "headline": "Solventum (SOLV) Beats Q2 Earnings and Revenue Estimates",
    "summary": "Solventum (SOLV) delivered earnings and revenue surprises of +16.55% and +1.87%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=08a2e5cda4a880c99fa4b8cb4b08cdaf850e48b14be493398f7b6b4366ea8a24",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754601903,
      "headline": "Solventum (SOLV) Beats Q2 Earnings and Revenue Estimates",
      "id": 136268114,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SOLV",
      "source": "Yahoo",
      "summary": "Solventum (SOLV) delivered earnings and revenue surprises of +16.55% and +1.87%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=08a2e5cda4a880c99fa4b8cb4b08cdaf850e48b14be493398f7b6b4366ea8a24"
    }
  },
  {
    "ts": null,
    "headline": "Solventum raises annual profit forecast on strength in surgical equipment",
    "summary": "Medical device makers have benefited from a surge in demand as more people, particularly older Americans, seek health care services and surgical procedures.  Minnesota-based Solventum is one of the largest providers of sterilization devices, wound dressings, medical tape and other hospital consumables used by healthcare facilities.  More than half of its revenue comes from its MedSurg business, which provides wound dressings and surgical equipment.",
    "url": "https://finnhub.io/api/news?id=5eb316df61c7c2a59a28625135d72335dd723b5b22d2845816f13fea595600f6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754599946,
      "headline": "Solventum raises annual profit forecast on strength in surgical equipment",
      "id": 136267957,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SOLV",
      "source": "Yahoo",
      "summary": "Medical device makers have benefited from a surge in demand as more people, particularly older Americans, seek health care services and surgical procedures.  Minnesota-based Solventum is one of the largest providers of sterilization devices, wound dressings, medical tape and other hospital consumables used by healthcare facilities.  More than half of its revenue comes from its MedSurg business, which provides wound dressings and surgical equipment.",
      "url": "https://finnhub.io/api/news?id=5eb316df61c7c2a59a28625135d72335dd723b5b22d2845816f13fea595600f6"
    }
  },
  {
    "ts": null,
    "headline": "Solventum: Q2 Earnings Snapshot",
    "summary": "The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.45 per share. The health care company posted revenue of $2.16 billion in the period, also exceeding Street forecasts.",
    "url": "https://finnhub.io/api/news?id=bd07c5536396e5b0986798c69091db89b78d91dc08193859ed7736274772bfaf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754597937,
      "headline": "Solventum: Q2 Earnings Snapshot",
      "id": 136268116,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SOLV",
      "source": "Yahoo",
      "summary": "The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.45 per share. The health care company posted revenue of $2.16 billion in the period, also exceeding Street forecasts.",
      "url": "https://finnhub.io/api/news?id=bd07c5536396e5b0986798c69091db89b78d91dc08193859ed7736274772bfaf"
    }
  },
  {
    "ts": null,
    "headline": "Solventum’s (NYSE:SOLV) Q2: Beats On Revenue",
    "summary": "Healthcare solutions provider Solventum (NYSE:SOLV) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.8% year on year to $2.16 billion. Its non-GAAP profit of $1.69 per share was 16.3% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=ce3fb76cd7940465c06c3fab17500af5eb9d63b49ee696f490dc21cfb7a97e59",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754597792,
      "headline": "Solventum’s (NYSE:SOLV) Q2: Beats On Revenue",
      "id": 136268117,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SOLV",
      "source": "Yahoo",
      "summary": "Healthcare solutions provider Solventum (NYSE:SOLV) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.8% year on year to $2.16 billion. Its non-GAAP profit of $1.69 per share was 16.3% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=ce3fb76cd7940465c06c3fab17500af5eb9d63b49ee696f490dc21cfb7a97e59"
    }
  },
  {
    "ts": null,
    "headline": "Solventum Reports Second Quarter 2025 Financial Results",
    "summary": "Solventum (NYSE: SOLV) today reported financial results for the second quarter ended June 30, 2025.",
    "url": "https://finnhub.io/api/news?id=a1ddcba9c3df3e7ec676ebf47ed0733260b029f31f0e15169d6636fb57e004e8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754597100,
      "headline": "Solventum Reports Second Quarter 2025 Financial Results",
      "id": 136268118,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SOLV",
      "source": "Yahoo",
      "summary": "Solventum (NYSE: SOLV) today reported financial results for the second quarter ended June 30, 2025.",
      "url": "https://finnhub.io/api/news?id=a1ddcba9c3df3e7ec676ebf47ed0733260b029f31f0e15169d6636fb57e004e8"
    }
  }
]